Ecteinascidin 743 in Treating Patients With Unresectable Advanced or Metastatic Soft Tissue Sarcoma

NCT00017030 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: trabectedin

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]